Please use this identifier to cite or link to this item:
|Title:||Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma|
|Keywords:||Intensity-modulated radiation therapy|
|Citation:||Qiu, S., Lin, S., Tham, I.W.K., Pan, J., Lu, J., Lu, J.J. (2012-06-01). Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. International Journal of Radiation Oncology Biology Physics 83 (2) : 676-683. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijrobp.2011.07.006|
|Abstract:||Purpose: Local recurrences of nasopharyngeal carcinoma (NPC) may be salvaged by reirradiation with conventional techniques, but with significant morbidity. Intensity-modulated radiation therapy (IMRT) may improve the therapeutic ratio by reducing doses to normal tissue. The aim of this study was to address the efficacy and toxicity profile of IMRT for a cohort of patients with locally recurrent NPC. Methods and Materials: Between August 2003 and June 2009, 70 patients with radiologic or pathologically proven locally recurrent NPC were treated with IMRT. The median time to recurrence was 30 months after the completion of conventional radiation to definitive dose. Fifty-seven percent of the tumors were classified asrT3-4. The minimum planned doses were 59.4 to 60 Gy in 1.8- to 2-Gy fractions per day to the gross disease with margins, with or without chemotherapy. Results: The median dose to the recurrent tumor was 70 Gy (range, 50-77.4 Gy). Sixty-five patients received the planned radiation therapy; 5 patients received between 50 and 60 Gy because of acute side effects. With a median follow-up time of 25 months, the rates of 2-year locoregional recurrence-free survival, disease-free survival, and overall survival were 65.8%, 65.8%, and 67.4%, respectively. Moderate to severe late toxicities were noted in 25 patients (35.7%). Eleven patients (15.7%) had posterior nasal space ulceration, 17 (24.3%) experienced cranial nerve palsies, 12 (17.1%) had trismus, and 12 (17.1%) experienced deafness. Extended disease-free interval (relative risk 2.049) and advanced T classification (relative risk 3.895) at presentation were adverse prognostic factors. Conclusion: Reirradiation with IMRT provides reasonable long-term control in patients with locally recurrent NPC. © 2012 Elsevier Inc. All rights reserved.|
|Source Title:||International Journal of Radiation Oncology Biology Physics|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 24, 2018
WEB OF SCIENCETM
checked on Sep 17, 2018
checked on Jul 26, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.